All News about Adma Biologics
![](/next-assets/images/schema-image-default.png)
Recap: ADMA Biologics Q1 Earnings
May 10, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
A Preview Of ADMA Biologics's Earnings
May 09, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
From ADMA Biologics, Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For ADMA Biologics
March 22, 2023
Via Benzinga
Looking Into ADMA Biologics's Return On Capital Employed
December 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/24/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/24/image17.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/24/image36.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/24/oxford-logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/23/laboratory-g7edffda9d_1920.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_197.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-fingers.jpg)
![](https://investorplace.com/wp-content/uploads/2019/08/healthcare1600c.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/10/jim_cramer_scotte_beale.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/31/wall_street_bull_shutter.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
December 07, 2022
From ADMA Biologics, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Proposed Public Offering of Common Stock
December 06, 2022
From ADMA Biologics, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/10/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/11/image_6.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.